{
    "body_text": [
        {
            "endOffset": 19071,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "Due to the extensive and diverse topic of gestational diabetes mellitus, the search was limited to systematic reviews conducted in the prior five years.",
            "startOffset": 18919,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for gestational diabetes mellitus as an adverse events following immunization"
        },
        {
            "endOffset": 35528,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                },
                {
                    "id": "s0110",
                    "title": "Data collection"
                },
                {
                    "id": "s0120",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "s0130",
            "sentence": "Past medical history, including hospitalizations, underlying diseases/disorders, pre-immunization signs and symptoms including identification of indicators for, or the absence of, a history of allergy to vaccines, vaccine components or medications; food allergy; allergic rhinitis; eczema; asthma.",
            "startOffset": 35231,
            "title": "Clinical and immunization history"
        },
        {
            "endOffset": 24429,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of gestational diabetes mellitus as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "As maximum specificity normally implies a loss of sensitivity, two additional diagnostic levels have been included in the definition, offering a stepwise increase of sensitivity from Level One down to Level Three, while retaining an acceptable level of specificity at all levels.",
            "startOffset": 24150,
            "title": "Formulating a case definition that reflects diagnostic certainty: weighing specificity versus sensitivity"
        },
        {
            "endOffset": 16832,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "We have excluded treatment of GDM, as well as maternal, fetal and neonatal complications attributed to GDM as these poor outcomes were likely due to GDM and other co-morbidities, not directly to the vaccine.",
            "startOffset": 16625,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for gestational diabetes mellitus as an adverse event following immunization"
        },
        {
            "endOffset": 28127,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Case definition of gestational diabetes mellitus3If the reporting center is different from the vaccinating center, appropriate and timely communication of the adverse event should occur.3"
                }
            ],
            "secId": "s0075",
            "sentence": "Previous diagnosis of diabetes while not pregnant",
            "startOffset": 28078,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 47476,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                }
            ],
            "secId": "s0155",
            "sentence": "However, the mean and standard deviation should also be provided.",
            "startOffset": 47411,
            "title": "Data presentation"
        },
        {
            "endOffset": 38534,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                },
                {
                    "id": "s0110",
                    "title": "Data collection"
                }
            ],
            "secId": "s0140",
            "sentence": "Values and units of routinely measured parameters (e.g. blood glucose levels including fasting and postprandial measurements, temperature, blood pressure) \u2013 in particular those indicating the severity of the event;",
            "startOffset": 38320,
            "title": "The adverse event"
        },
        {
            "endOffset": 38250,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                },
                {
                    "id": "s0110",
                    "title": "Data collection"
                }
            ],
            "secId": "s0140",
            "sentence": "Date/time of onset,4 first observation5 and diagnosis,6 end of episode7 and final outcome.8",
            "startOffset": 37376,
            "title": "The adverse event"
        },
        {
            "endOffset": 49052,
            "parents": [],
            "secId": "s0160",
            "sentence": "They do not necessarily represent the official positions of each participant\u2019s organization (e.g., government, university, or corporation).",
            "startOffset": 48913,
            "title": "Disclaimer"
        },
        {
            "endOffset": 34699,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                },
                {
                    "id": "s0110",
                    "title": "Data collection"
                },
                {
                    "id": "s0120",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "s0125",
            "sentence": "Case/study participant identifiers (e.g. first name initial followed by last name initial with medical record number/booking number/subject number) or alpha-numeric code (or in accordance with country-specific data protection laws).",
            "startOffset": 34467,
            "title": "Demographics"
        },
        {
            "endOffset": 46288,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                }
            ],
            "secId": "s0155",
            "sentence": "All reported events of GDM should be presented according to the categories listed in guideline 32.",
            "startOffset": 46190,
            "title": "Data presentation"
        },
        {
            "endOffset": 28252,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Case definition of gestational diabetes mellitus3If the reporting center is different from the vaccinating center, appropriate and timely communication of the adverse event should occur.3"
                }
            ],
            "secId": "s0075",
            "sentence": "First trimester fasting blood glucose 126 mg/dL/\u2a7e7 mmol/L",
            "startOffset": 28195,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 36188,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                },
                {
                    "id": "s0110",
                    "title": "Data collection"
                },
                {
                    "id": "s0120",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "s0130",
            "sentence": "Immunization history (i.e. previous immunizations and any adverse event following immunization (AEFI)), in particular occurrence of GDM after a previous immunization.",
            "startOffset": 36022,
            "title": "Clinical and immunization history"
        },
        {
            "endOffset": 42612,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                }
            ],
            "secId": "s0150",
            "sentence": "Level 3: Criteria as specified in the GDM case definition",
            "startOffset": 42555,
            "title": "Data analysis"
        },
        {
            "endOffset": 36809,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                },
                {
                    "id": "s0110",
                    "title": "Data collection"
                }
            ],
            "secId": "s0135",
            "sentence": "The anatomical sites (including left or right side) of all immunizations (e.g. vaccine A in proximal left lateral thigh, vaccine B in left deltoid).",
            "startOffset": 36661,
            "title": "Details of the immunization"
        },
        {
            "endOffset": 20474,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "((maternal NEXT/1 (vaccin\u2217 OR immuniz\u2217 OR immunis\u2217)) OR ((('vaccine'/exp/mj OR 'immunization'/exp/mj OR vaccin\u2217:ti OR immuniz\u2217:ti OR immunis\u2217:ti OR revaccin\u2217:ti OR postvaccin\u2217:ti OR reimmuni\u2217:ti OR postimmuni\u2217) AND ('pregnancy'/exp/mj OR 'child bearing':ti OR 'childbearing':ti OR 'gestation':ti OR 'gravidity':ti OR ((labor OR labor) NEXT/1 presentation):ti ORpregnan\u2217:ti OR 'pregnant woman'/exp/mj OR 'expectant mother'/exp/mj OR (expectant NEXT/1 mother\u2217) AND ('pregnancy diabetes mellitus'/exp AND diabetes NEAR/2 (gestational OR pregnancy))",
            "startOffset": 19929,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for gestational diabetes mellitus as an adverse events following immunization"
        },
        {
            "endOffset": 20806,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "Differences in literature review were adjudicated by a third committee member.",
            "startOffset": 20728,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for gestational diabetes mellitus as an adverse events following immunization"
        },
        {
            "endOffset": 21897,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "The specific glucose tolerance test as well as the glucose level cut-offs vary between reviews and consensus guidelines.",
            "startOffset": 21777,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for gestational diabetes mellitus as an adverse events following immunization"
        },
        {
            "endOffset": 25062,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of gestational diabetes mellitus as an adverse event following immunization"
                }
            ],
            "secId": "s0050",
            "sentence": "GDM is usually diagnosed in the second or third trimester of pregnancy, related to increasing pregnancy-related insulin resistance.",
            "startOffset": 24931,
            "title": "Timing post immunization"
        },
        {
            "endOffset": 48150,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                }
            ],
            "secId": "s0155",
            "sentence": "Comparison group(s), if used for analysis.",
            "startOffset": 48108,
            "title": "Data presentation"
        },
        {
            "endOffset": 26617,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of gestational diabetes mellitus as an adverse event following immunization"
                }
            ],
            "secId": "s0050",
            "sentence": "In order to avoid selecting against such cases, the Brighton Collaboration case definition avoids setting arbitrary time frames.",
            "startOffset": 26489,
            "title": "Timing post immunization"
        },
        {
            "endOffset": 34730,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                },
                {
                    "id": "s0110",
                    "title": "Data collection"
                },
                {
                    "id": "s0120",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "s0125",
            "sentence": "Date of birth, age, and sex.",
            "startOffset": 34702,
            "title": "Demographics"
        },
        {
            "endOffset": 29038,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Case definition of gestational diabetes mellitus3If the reporting center is different from the vaccinating center, appropriate and timely communication of the adverse event should occur.3"
                }
            ],
            "secId": "s0085",
            "sentence": "Absence of pregestational diabetes mellitus diagnosis in the first trimester as defined above with level 1\u20132 certainty for gestational age using GAIA definition for gestational age (please see Appendix A)",
            "startOffset": 28834,
            "title": "Level 2 of diagnostic certainty"
        },
        {
            "endOffset": 45702,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                }
            ],
            "secId": "s0155",
            "sentence": "These guidelines represent a desirable standard for the presentation and publication of data on GDM following immunization to allow for comparability of data, and are recommended as an addition to data presented for the specific study question and setting.",
            "startOffset": 45446,
            "title": "Data presentation"
        },
        {
            "endOffset": 28387,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Case definition of gestational diabetes mellitus3If the reporting center is different from the vaccinating center, appropriate and timely communication of the adverse event should occur.3"
                }
            ],
            "secId": "s0075",
            "sentence": "Identification of sustained hyperglycemia during pregnancy not due to other known causes (i.e. corticosteroids, beta-mimetics, etc.)",
            "startOffset": 28255,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 24850,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of gestational diabetes mellitus as an adverse event following immunization"
                }
            ],
            "secId": "s0050",
            "sentence": "Timing criteria for considering GDM as a possible adverse event from vaccination are important.",
            "startOffset": 24755,
            "title": "Timing post immunization"
        },
        {
            "endOffset": 44598,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                }
            ],
            "secId": "s0150",
            "sentence": "The distribution of data (as numerator and denominator data) could be analyzed in predefined increments (e.g. measured values, times), where applicable.",
            "startOffset": 44446,
            "title": "Data analysis"
        },
        {
            "endOffset": 42647,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                }
            ],
            "secId": "s0150",
            "sentence": "Event does not meet case definition",
            "startOffset": 42612,
            "title": "Data analysis"
        },
        {
            "endOffset": 23942,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of gestational diabetes mellitus as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "Detailed information about the severity of the event should additionally always be recorded, as specified by the data collection guidelines.",
            "startOffset": 23802,
            "title": "Formulating a case definition that reflects diagnostic certainty: weighing specificity versus sensitivity"
        },
        {
            "endOffset": 35228,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                },
                {
                    "id": "s0110",
                    "title": "Data collection"
                },
                {
                    "id": "s0120",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "s0130",
            "sentence": "For the purposes of this definition, any hyperglycemia or diabetes diagnosis prior to current pregnancy or between pregnancies.",
            "startOffset": 35101,
            "title": "Clinical and immunization history"
        },
        {
            "endOffset": 42405,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                }
            ],
            "secId": "s0150",
            "sentence": "Event classification in 5 categories10",
            "startOffset": 41535,
            "title": "Data analysis"
        },
        {
            "endOffset": 15291,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "While these studies did not find an increased incidence of GDM after maternal immunization, they had multiple confounders [14\u201322].",
            "startOffset": 15161,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for gestational diabetes mellitus as an adverse event following immunization"
        },
        {
            "endOffset": 33628,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                }
            ],
            "secId": "s0110",
            "sentence": "These data elements include an identifiable reporter and patient, one or more prior immunizations, and a detailed description of the adverse event, in this case, of GDM following immunization.",
            "startOffset": 33436,
            "title": "Data collection"
        },
        {
            "endOffset": 18918,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "To guide the decision-making for the case definition and guidelines, a literature search was performed using MEDLINE and Embase databases.",
            "startOffset": 18780,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for gestational diabetes mellitus as an adverse events following immunization"
        },
        {
            "endOffset": 28077,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Case definition of gestational diabetes mellitus3If the reporting center is different from the vaccinating center, appropriate and timely communication of the adverse event should occur.3"
                }
            ],
            "secId": "s0075",
            "sentence": "The absence of pre-gestational diabetes diagnosis defined by",
            "startOffset": 28017,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 36657,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                },
                {
                    "id": "s0110",
                    "title": "Data collection"
                }
            ],
            "secId": "s0135",
            "sentence": "If applicable, description of diluent (manufacturer, lot number, amount (e.g. 0.25 mL, 0.5 mL, etc.)",
            "startOffset": 36557,
            "title": "Details of the immunization"
        },
        {
            "endOffset": 16968,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "There is wide variation for the diagnostic criteria for GDM globally depending on country, consensus statements and resources available.",
            "startOffset": 16832,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for gestational diabetes mellitus as an adverse event following immunization"
        },
        {
            "endOffset": 27441,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0060",
            "sentence": "Neither case definition nor guidelines are intended to guide or establish criteria for management of ill infants, children, or adults.",
            "startOffset": 27307,
            "title": "Guidelines for data collection, analysis and presentation"
        },
        {
            "endOffset": 29791,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Case definition of gestational diabetes mellitus3If the reporting center is different from the vaccinating center, appropriate and timely communication of the adverse event should occur.3"
                }
            ],
            "secId": "s0090",
            "sentence": "Diagnosis of gestational diabetes based on fasting plasma glucose of 5.1\u20136.9 mmol/l (92\u2013125 mg/dL) using venous or capillary blood samples.",
            "startOffset": 29652,
            "title": "Level 3 of diagnostic certainty"
        },
        {
            "endOffset": 12267,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Gestational diabetes mellitus (GDM) is a common condition in pregnancy that can result in significant morbidity and mortality to both mother and fetus.",
            "startOffset": 12116,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for gestational diabetes mellitus as an adverse event following immunization"
        },
        {
            "endOffset": 34208,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                },
                {
                    "id": "s0110",
                    "title": "Data collection"
                }
            ],
            "secId": "s0115",
            "sentence": "Name and contact information of the investigator responsible for the subject, as applicable.",
            "startOffset": 34116,
            "title": "Source of information/reporter"
        },
        {
            "endOffset": 36326,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                },
                {
                    "id": "s0110",
                    "title": "Data collection"
                }
            ],
            "secId": "s0135",
            "sentence": "For all cases and/or all study participants, as appropriate, the following information should be recorded:",
            "startOffset": 36220,
            "title": "Details of the immunization"
        },
        {
            "endOffset": 12555,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Approximately 16% of these women will have pre-existing diabetes mellitus, diagnosed prior to pregnancy or during the first trimester of pregnancy.",
            "startOffset": 12408,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for gestational diabetes mellitus as an adverse event following immunization"
        },
        {
            "endOffset": 29459,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Case definition of gestational diabetes mellitus3If the reporting center is different from the vaccinating center, appropriate and timely communication of the adverse event should occur.3"
                }
            ],
            "secId": "s0090",
            "sentence": "Absence of pregestational diabetes mellitus diagnosis in the first trimester as defined above with at least level 3 certainty for gestational age using GAIA definition for gestational age (please see Appendix A)",
            "startOffset": 29248,
            "title": "Level 3 of diagnostic certainty"
        },
        {
            "endOffset": 39640,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                },
                {
                    "id": "s0110",
                    "title": "Data collection"
                }
            ],
            "secId": "s0140",
            "sentence": "Exposures other than the immunization 24 h before and after immunization (e.g. food, environmental, pharmaceutical) considered potentially relevant to the reported event.",
            "startOffset": 39470,
            "title": "The adverse event"
        },
        {
            "endOffset": 49211,
            "parents": [],
            "secId": "s0160",
            "sentence": "Specifically, the findings and conclusions in this paper are those of the authors and do not necessarily represent the views of their respective institutions.",
            "startOffset": 49053,
            "title": "Disclaimer"
        },
        {
            "endOffset": 25792,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of gestational diabetes mellitus as an adverse event following immunization"
                }
            ],
            "secId": "s0050",
            "sentence": "Timed criteria should be used, since development of hyperglycemia in pregnancy can occur at any time in the second and third trimesters of pregnancy and vaccinations are usually administered in the 1st and 3rd trimesters of pregnancy.",
            "startOffset": 25558,
            "title": "Timing post immunization"
        },
        {
            "endOffset": 29650,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Case definition of gestational diabetes mellitus3If the reporting center is different from the vaccinating center, appropriate and timely communication of the adverse event should occur.3"
                }
            ],
            "secId": "s0090",
            "sentence": "Diagnosis of gestational diabetes based on positive internationally recognized oral glucose tolerance test (see below \u201cmajor criteria\u201d) using venous blood or capillary blood sample/samples",
            "startOffset": 29462,
            "title": "Level 3 of diagnostic certainty"
        },
        {
            "endOffset": 47958,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                }
            ],
            "secId": "s0155",
            "sentence": "The type of surveillance (e.g. passive or active surveillance).",
            "startOffset": 47895,
            "title": "Data presentation"
        },
        {
            "endOffset": 15160,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Multiple large prospective and retrospective vaccination studies have included GDM as a potential adverse outcome, often relying on ICD-9 or ICD-10 codes for diagnosis.",
            "startOffset": 14992,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for gestational diabetes mellitus as an adverse event following immunization"
        },
        {
            "endOffset": 22585,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of gestational diabetes mellitus as an adverse event following immunization"
                }
            ],
            "secId": "s0025",
            "sentence": "Alternate terminology for GDM includes \u201cpregnancy-induced hyperglycemia.\u201d",
            "startOffset": 22512,
            "title": "The term gestational diabetes mellitus"
        },
        {
            "endOffset": 48107,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                }
            ],
            "secId": "s0155",
            "sentence": "The search strategy in surveillance databases.",
            "startOffset": 48061,
            "title": "Data presentation"
        },
        {
            "endOffset": 15886,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Other medications, such as corticosteroids and beta-mimetics, are known to alter glucose tolerance, although only transiently [13].",
            "startOffset": 15755,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for gestational diabetes mellitus as an adverse event following immunization"
        },
        {
            "endOffset": 21776,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "In the majority of cases, oral glucose tolerance tests were used to diagnose gestational diabetes with venous blood draws.",
            "startOffset": 21654,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for gestational diabetes mellitus as an adverse events following immunization"
        },
        {
            "endOffset": 47642,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                }
            ],
            "secId": "s0155",
            "sentence": "It is essential to specify:",
            "startOffset": 47615,
            "title": "Data presentation"
        },
        {
            "endOffset": 15405,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "One of these confounders is the specific timing of vaccinations in pregnancy in relation to the diagnosis of GDM.",
            "startOffset": 15292,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for gestational diabetes mellitus as an adverse event following immunization"
        },
        {
            "endOffset": 42552,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                }
            ],
            "secId": "s0150",
            "sentence": "Level 2: Criteria as specified in the GDM case definition",
            "startOffset": 42495,
            "title": "Data analysis"
        },
        {
            "endOffset": 33951,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                },
                {
                    "id": "s0110",
                    "title": "Data collection"
                }
            ],
            "secId": "s0115",
            "sentence": "For all cases and/or all study participants, as appropriate, the following information should be recorded:",
            "startOffset": 33845,
            "title": "Source of information/reporter"
        },
        {
            "endOffset": 22310,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "Please contact the corresponding author for further information.",
            "startOffset": 22246,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for gestational diabetes mellitus as an adverse events following immunization"
        },
        {
            "endOffset": 26488,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of gestational diabetes mellitus as an adverse event following immunization"
                }
            ],
            "secId": "s0050",
            "sentence": "In some settings it may be impossible to obtain a clear timeline of the event, particularly in less developed or rural settings.",
            "startOffset": 26360,
            "title": "Timing post immunization"
        },
        {
            "endOffset": 36964,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                },
                {
                    "id": "s0110",
                    "title": "Data collection"
                }
            ],
            "secId": "s0135",
            "sentence": "Route and method of administration (e.g. intramuscular, intradermal, subcutaneous, and needle-free (including type and size), other injection devices).",
            "startOffset": 36813,
            "title": "Details of the immunization"
        },
        {
            "endOffset": 47718,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                }
            ],
            "secId": "s0155",
            "sentence": "The method, frequency and duration of monitoring for GDM.",
            "startOffset": 47661,
            "title": "Data presentation"
        },
        {
            "endOffset": 47614,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                }
            ],
            "secId": "s0155",
            "sentence": "Any publication of data on GDM should include a detailed description of the methods used for data collection and analysis as possible.",
            "startOffset": 47480,
            "title": "Data presentation"
        },
        {
            "endOffset": 47894,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                }
            ],
            "secId": "s0155",
            "sentence": "The trial profile, indicating participant flow during a study including drop-outs and withdrawals to indicate the size and nature of the respective groups under investigation.",
            "startOffset": 47719,
            "title": "Data presentation"
        },
        {
            "endOffset": 23225,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of gestational diabetes mellitus as an adverse event following immunization"
                }
            ],
            "secId": "s0030",
            "sentence": "Type 2 DM: Type 2 DM is the more common form of pregestational DM.",
            "startOffset": 23159,
            "title": "Related term(s) of gestational diabetes mellitus"
        },
        {
            "endOffset": 14234,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study demonstrated a continuous association between maternal glucose levels and increased birth weight, cesarean section deliveries and neonatal hyperinsulinemia [8].",
            "startOffset": 14013,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for gestational diabetes mellitus as an adverse event following immunization"
        },
        {
            "endOffset": 22936,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of gestational diabetes mellitus as an adverse event following immunization"
                }
            ],
            "secId": "s0030",
            "sentence": "Two subtypes are frequently described:",
            "startOffset": 22898,
            "title": "Related term(s) of gestational diabetes mellitus"
        },
        {
            "endOffset": 33020,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                }
            ],
            "secId": "s0110",
            "sentence": "Investigators developing a data collection tool based on these data collection guidelines also need to refer to the criteria in the case definition, which are not repeated in these guidelines.",
            "startOffset": 32828,
            "title": "Data collection"
        },
        {
            "endOffset": 47410,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                }
            ],
            "secId": "s0155",
            "sentence": "If the distribution of data is skewed, median and range are usually the more appropriate statistical descriptors than a mean.",
            "startOffset": 47285,
            "title": "Data presentation"
        },
        {
            "endOffset": 15557,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Vaccinations are predominantly administered in the first and third trimesters, and GDM testing and diagnosis occurs in the second and third trimesters.",
            "startOffset": 15406,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for gestational diabetes mellitus as an adverse event following immunization"
        },
        {
            "endOffset": 18780,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "The composition of the working and reference group as well as results of the web-based survey completed by the reference group with subsequent discussions in the working group can be viewed at: http://www.brightoncollaboration.org/internet/en/index/working_groups.html.",
            "startOffset": 18511,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for gestational diabetes mellitus as an adverse events following immunization"
        },
        {
            "endOffset": 30231,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Case definition of gestational diabetes mellitus3If the reporting center is different from the vaccinating center, appropriate and timely communication of the adverse event should occur.3"
                }
            ],
            "secId": "s0095",
            "sentence": "Elevated postprandial blood glucose level without confirmatory fasting venous blood or capillary glucose level",
            "startOffset": 30121,
            "title": "Insufficient evidence for diagnosis of gestational diabetes mellitus"
        },
        {
            "endOffset": 23393,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of gestational diabetes mellitus as an adverse event following immunization"
                }
            ],
            "secId": "s0030",
            "sentence": "It is characterized by insulin resistance or relative insulin deficiency and can be treated by dietary and lifestyle modifications, oral agents and/or insulin therapy.",
            "startOffset": 23226,
            "title": "Related term(s) of gestational diabetes mellitus"
        },
        {
            "endOffset": 37372,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                },
                {
                    "id": "s0110",
                    "title": "Data collection"
                }
            ],
            "secId": "s0140",
            "sentence": "Clinical description of signs and symptoms of GDM, and if there was medical confirmation of the event (i.e. patient seen by qualified health professional).",
            "startOffset": 37217,
            "title": "The adverse event"
        },
        {
            "endOffset": 23032,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of gestational diabetes mellitus as an adverse event following immunization"
                }
            ],
            "secId": "s0030",
            "sentence": "Type 1 DM: Type 1 DM typically has an onset early in life usually due to an autoimmune process.",
            "startOffset": 22937,
            "title": "Related term(s) of gestational diabetes mellitus"
        },
        {
            "endOffset": 46186,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                }
            ],
            "secId": "s0155",
            "sentence": "Additionally, it is recommended to refer to existing general guidelines for the presentation and publication of randomized controlled trials, systematic reviews, and meta-analyses of observational studies in epidemiology (e.g. statements of Consolidated Standards of Reporting Trials (CONSORT), of Improving the quality of reports of meta-analyses of randomized controlled trials (QUORUM), and of meta-analysis Of Observational Studies in Epidemiology (MOOSE), respectively) [30\u201332].",
            "startOffset": 45703,
            "title": "Data presentation"
        },
        {
            "endOffset": 13605,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "However it has been found that screening based on these factors will miss approximately 50% of women with GDM [5].",
            "startOffset": 13491,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for gestational diabetes mellitus as an adverse event following immunization"
        },
        {
            "endOffset": 12584,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "The remainder will have GDM.",
            "startOffset": 12556,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for gestational diabetes mellitus as an adverse event following immunization"
        },
        {
            "endOffset": 23065,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of gestational diabetes mellitus as an adverse event following immunization"
                }
            ],
            "secId": "s0030",
            "sentence": "It necessitates insulin therapy.",
            "startOffset": 23033,
            "title": "Related term(s) of gestational diabetes mellitus"
        },
        {
            "endOffset": 43195,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                }
            ],
            "secId": "s0150",
            "sentence": "Not a case of GDM12",
            "startOffset": 42954,
            "title": "Data analysis"
        },
        {
            "endOffset": 47167,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                }
            ],
            "secId": "s0155",
            "sentence": "The source of the denominator data should be reported and calculations of estimates be described (e.g. manufacturer data like total doses distributed, reporting through Ministry of Health, coverage/population based data, etc.).",
            "startOffset": 46940,
            "title": "Data presentation"
        },
        {
            "endOffset": 44641,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                }
            ],
            "secId": "s0150",
            "sentence": "Increments specified above should be used.",
            "startOffset": 44599,
            "title": "Data analysis"
        },
        {
            "endOffset": 31510,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Case definition of gestational diabetes mellitus3If the reporting center is different from the vaccinating center, appropriate and timely communication of the adverse event should occur.3"
                }
            ],
            "secId": "s0100",
            "sentence": "Postpartum or interpregnancy GTTs, however, are infrequently performed and therefore the absence of this test would not be exclusionary.",
            "startOffset": 31374,
            "title": "Major and minor criteria used in the case definition of gestational diabetes mellitus"
        },
        {
            "endOffset": 31934,
            "parents": [],
            "secId": "s0105",
            "sentence": "However, implementation of all guidelines might not be possible in all settings.",
            "startOffset": 31854,
            "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
        },
        {
            "endOffset": 48060,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                }
            ],
            "secId": "s0155",
            "sentence": "The characteristics of the surveillance system (e.g. population served, mode of report solicitation).",
            "startOffset": 47959,
            "title": "Data presentation"
        },
        {
            "endOffset": 43540,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                }
            ],
            "secId": "s0150",
            "sentence": "If few cases are reported, the concrete time course could be analyzed for each; for a large number of cases, data can be analyzed in the following increments:",
            "startOffset": 43382,
            "title": "Data analysis"
        },
        {
            "endOffset": 45426,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                }
            ],
            "secId": "s0150",
            "sentence": "Ultimately, careful analysis of data is necessary given overlap between usual timing of vaccination in pregnancy and routine GDM screening between 24 and 28 weeks gestational age in order to avoid misleading conclusions regarding GDM and associations with vaccinations purely based on timing of vaccine administration and GDM diagnosis.",
            "startOffset": 45090,
            "title": "Data analysis"
        },
        {
            "endOffset": 25558,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of gestational diabetes mellitus as an adverse event following immunization"
                }
            ],
            "secId": "s0050",
            "sentence": "Future studies on time intervals between maternal immunizations and GDM are needed (please see Section 3.2).",
            "startOffset": 25450,
            "title": "Timing post immunization"
        },
        {
            "endOffset": 25987,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of gestational diabetes mellitus as an adverse event following immunization"
                }
            ],
            "secId": "s0050",
            "sentence": "We postulate that a definition designed to be a suitable tool for testing causal relationships requires ascertainment of the outcome (e.g. GDM) independent from the exposure (e.g. immunizations).",
            "startOffset": 25792,
            "title": "Timing post immunization"
        },
        {
            "endOffset": 29872,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Case definition of gestational diabetes mellitus3If the reporting center is different from the vaccinating center, appropriate and timely communication of the adverse event should occur.3"
                }
            ],
            "secId": "s0090",
            "sentence": "Glucometers should be calibrated according to local standards/research protocols.",
            "startOffset": 29791,
            "title": "Level 3 of diagnostic certainty"
        },
        {
            "endOffset": 31161,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Case definition of gestational diabetes mellitus3If the reporting center is different from the vaccinating center, appropriate and timely communication of the adverse event should occur.3"
                }
            ],
            "secId": "s0100",
            "sentence": "OGTT (Oral glucose tolerance test); IADPSG (International Association of Diabetes and Pregnancy Study Groups); WHO (World Health Organization); NICE (The National Institute for Health and Care Excellence, UK); NDDG (National Diabetes Data Group) (see Table 1).",
            "startOffset": 30901,
            "title": "Major and minor criteria used in the case definition of gestational diabetes mellitus"
        },
        {
            "endOffset": 33435,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                }
            ],
            "secId": "s0110",
            "sentence": "Guidelines 1\u201344 below have been developed to address data elements for the collection of adverse event information as specified in general drug safety guidelines by the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use [28], and the form for reporting of drug adverse events by the Council for International Organizations of Medical Sciences [29].",
            "startOffset": 33020,
            "title": "Data collection"
        },
        {
            "endOffset": 41535,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                }
            ],
            "secId": "s0150",
            "sentence": "Events that do not meet the case definition should be classified in the additional categories for analysis.",
            "startOffset": 41428,
            "title": "Data analysis"
        },
        {
            "endOffset": 27492,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0060",
            "sentence": "Both were developed to improve data comparability.",
            "startOffset": 27442,
            "title": "Guidelines for data collection, analysis and presentation"
        },
        {
            "endOffset": 35098,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                },
                {
                    "id": "s0110",
                    "title": "Data collection"
                },
                {
                    "id": "s0120",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "s0130",
            "sentence": "For all cases and/or all study participants, as appropriate, the following information should be recorded:",
            "startOffset": 34992,
            "title": "Clinical and immunization history"
        },
        {
            "endOffset": 16198,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Since this definition is not currently in use the studies included in this review have not limited the time between vaccination and diagnosis of GDM.",
            "startOffset": 16049,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for gestational diabetes mellitus as an adverse event following immunization"
        },
        {
            "endOffset": 19263,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "((\u201cpregnancy induced diabetes\u201d AND diagnosis) Filters: published in the last 5 years; Humans; English)",
            "startOffset": 19161,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for gestational diabetes mellitus as an adverse events following immunization"
        },
        {
            "endOffset": 24669,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of gestational diabetes mellitus as an adverse event following immunization"
                },
                {
                    "id": "s0040",
                    "title": "Rationale for individual criteria or decision made related to the case definition"
                }
            ],
            "secId": "s0045",
            "sentence": "Laboratory findings are crucial to the diagnosis of GDM.",
            "startOffset": 24613,
            "title": "Laboratory findings"
        },
        {
            "endOffset": 28192,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Case definition of gestational diabetes mellitus3If the reporting center is different from the vaccinating center, appropriate and timely communication of the adverse event should occur.3"
                }
            ],
            "secId": "s0075",
            "sentence": "First trimester hemoglobin A1c level of \u2a7e 6.5% (47.5 mmol/mol)",
            "startOffset": 28130,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 33810,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                }
            ],
            "secId": "s0110",
            "sentence": "The additional guidelines have been developed as guidance for the collection of additional information to allow for a more comprehensive understanding of GDM following immunization.",
            "startOffset": 33629,
            "title": "Data collection"
        },
        {
            "endOffset": 42951,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                }
            ],
            "secId": "s0150",
            "sentence": "Reported GDM with insufficient evidence to meet the case definition11",
            "startOffset": 42684,
            "title": "Data analysis"
        },
        {
            "endOffset": 13490,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Risk factors for GDM include family history of diabetes, GDM in prior pregnancy, ethnicity and obesity.",
            "startOffset": 13387,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for gestational diabetes mellitus as an adverse event following immunization"
        },
        {
            "endOffset": 38295,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                },
                {
                    "id": "s0110",
                    "title": "Data collection"
                }
            ],
            "secId": "s0140",
            "sentence": "Concurrent signs, symptoms, and diseases.",
            "startOffset": 38254,
            "title": "The adverse event"
        },
        {
            "endOffset": 34822,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                },
                {
                    "id": "s0110",
                    "title": "Data collection"
                },
                {
                    "id": "s0120",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "s0125",
            "sentence": "For infants: Gestational age and birth weight and length, and whether multiple gestation.",
            "startOffset": 34733,
            "title": "Demographics"
        },
        {
            "endOffset": 16514,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "If the baseline incidence in the study population is not known then determining the change in incidence after vaccination is not feasible.",
            "startOffset": 16376,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for gestational diabetes mellitus as an adverse event following immunization"
        },
        {
            "endOffset": 32198,
            "parents": [],
            "secId": "s0105",
            "sentence": "The availability of information may vary depending upon resources, geographical region, and whether the source of information is a prospective clinical trial, a post-marketing surveillance or epidemiological study, or an individual report of gestational diabetes.",
            "startOffset": 31935,
            "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
        },
        {
            "endOffset": 32449,
            "parents": [],
            "secId": "s0105",
            "sentence": "Also, as explained in more detail in the overview paper in this volume, these guidelines have been developed by this working group for guidance only, and are not to be considered a mandatory requirement for data collection, analysis, or presentation.",
            "startOffset": 32199,
            "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
        },
        {
            "endOffset": 13386,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "This is due to decreasing insulin sensitivity as the pregnancy progresses.",
            "startOffset": 13312,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for gestational diabetes mellitus as an adverse event following immunization"
        },
        {
            "endOffset": 19929,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "The following search string was used:",
            "startOffset": 19892,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for gestational diabetes mellitus as an adverse events following immunization"
        },
        {
            "endOffset": 20727,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "Of the search for gestational diabetes related to vaccinations, 11 of 14 were retained after review.",
            "startOffset": 20627,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for gestational diabetes mellitus as an adverse events following immunization"
        },
        {
            "endOffset": 46426,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                }
            ],
            "secId": "s0155",
            "sentence": "Data on possible GDM events should be presented in accordance with data collection guidelines 1\u201325 and data analysis guidelines 32\u201337.",
            "startOffset": 46292,
            "title": "Data presentation"
        },
        {
            "endOffset": 36553,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                },
                {
                    "id": "s0110",
                    "title": "Data collection"
                }
            ],
            "secId": "s0135",
            "sentence": "Description of vaccine(s) (name of vaccine, manufacturer, lot number, dose (e.g. 0.25 mL, 0.5 mL, etc.) and number of dose if part of a series of immunizations against the same disease).",
            "startOffset": 36367,
            "title": "Details of the immunization"
        },
        {
            "endOffset": 36992,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                },
                {
                    "id": "s0110",
                    "title": "Data collection"
                }
            ],
            "secId": "s0135",
            "sentence": "Needle length and gauge.",
            "startOffset": 36968,
            "title": "Details of the immunization"
        },
        {
            "endOffset": 42681,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                }
            ],
            "secId": "s0150",
            "sentence": "Additional categories for analysis",
            "startOffset": 42647,
            "title": "Data analysis"
        },
        {
            "endOffset": 44138,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                }
            ],
            "secId": "s0150",
            "sentence": "Whatever start and ending are used, they should be used consistently within and across study groups.",
            "startOffset": 44038,
            "title": "Data analysis"
        },
        {
            "endOffset": 16048,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Ideally, studies that examine the effect of vaccines on glucose tolerance would include a time period close to the vaccination administration, perhaps 0\u201314 days.",
            "startOffset": 15887,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for gestational diabetes mellitus as an adverse event following immunization"
        },
        {
            "endOffset": 21441,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "Each member of the Gestational Diabetes work group was assigned approximately eight of the 141 articles to review for identification of a working definition of gestational diabetes and the preferred method of diagnosing it or for describing any association of gestational diabetes as a complication of vaccination.",
            "startOffset": 21127,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for gestational diabetes mellitus as an adverse events following immunization"
        },
        {
            "endOffset": 30119,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Case definition of gestational diabetes mellitus3If the reporting center is different from the vaccinating center, appropriate and timely communication of the adverse event should occur.3"
                }
            ],
            "secId": "s0095",
            "sentence": "Blood glucose cannot be measured",
            "startOffset": 30087,
            "title": "Insufficient evidence for diagnosis of gestational diabetes mellitus"
        },
        {
            "endOffset": 30596,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Case definition of gestational diabetes mellitus3If the reporting center is different from the vaccinating center, appropriate and timely communication of the adverse event should occur.3"
                }
            ],
            "secId": "s0095",
            "sentence": "Clinical and laboratory findings such as glucosuria, fundal height greater than dates, obesity, prior history of GDM or family history for the diagnosis of gestational diabetes mellitus without a diagnostic test.",
            "startOffset": 30384,
            "title": "Insufficient evidence for diagnosis of gestational diabetes mellitus"
        },
        {
            "endOffset": 27306,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0060",
            "sentence": "As mentioned in the overview paper, the case definition is accompanied by guidelines that are structured according to the steps of conducting a clinical trial, i.e. data collection, analysis and presentation.",
            "startOffset": 27098,
            "title": "Guidelines for data collection, analysis and presentation"
        },
        {
            "endOffset": 16624,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "For this review, we have focused on the development of GDM as a possible adverse event following vaccination.",
            "startOffset": 16515,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for gestational diabetes mellitus as an adverse event following immunization"
        },
        {
            "endOffset": 46776,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                }
            ],
            "secId": "s0155",
            "sentence": "Data should be presented with numerator and denominator (n/N) (and not only in percentages), if available.",
            "startOffset": 46670,
            "title": "Data presentation"
        },
        {
            "endOffset": 21070,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "Fifteen national endocrine and obstetrics and gynecology guidelines were reviewed.",
            "startOffset": 20988,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for gestational diabetes mellitus as an adverse events following immunization"
        },
        {
            "endOffset": 29214,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Case definition of gestational diabetes mellitus3If the reporting center is different from the vaccinating center, appropriate and timely communication of the adverse event should occur.3"
                }
            ],
            "secId": "s0085",
            "sentence": "Diagnosis of gestational diabetes based on positive internationally recognized oral glucose tolerance test (see below \u201cmajor criteria\u201d) using capillary blood sample/samples.",
            "startOffset": 29041,
            "title": "Level 2 of diagnostic certainty"
        },
        {
            "endOffset": 15662,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "This inevitably leads to the diagnosis of GDM after vaccine administration has occurred or concurrently.",
            "startOffset": 15558,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for gestational diabetes mellitus as an adverse event following immunization"
        },
        {
            "endOffset": 47281,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                }
            ],
            "secId": "s0155",
            "sentence": "The incidence of cases in the study population should be presented and clearly identified as such in the text.",
            "startOffset": 47171,
            "title": "Data presentation"
        },
        {
            "endOffset": 17641,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "In resource-limited settings, alternative methods of diagnosis have been proposed including fasting glucose levels, glucosuria or diagnosis based on other risk factors.",
            "startOffset": 17473,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for gestational diabetes mellitus as an adverse event following immunization"
        },
        {
            "endOffset": 24038,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of gestational diabetes mellitus as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "The number of symptoms and/or signs that will be documented for each case may vary considerably.",
            "startOffset": 23942,
            "title": "Formulating a case definition that reflects diagnostic certainty: weighing specificity versus sensitivity"
        },
        {
            "endOffset": 26359,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of gestational diabetes mellitus as an adverse event following immunization"
                }
            ],
            "secId": "s0050",
            "sentence": "Further, GDM usually occurs outside the controlled setting of a clinical trial or hospital.",
            "startOffset": 26268,
            "title": "Timing post immunization"
        },
        {
            "endOffset": 20987,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "In addition, we identified latest edition Obstetrics and Gynecology text books in common usage in North America, Europe and Africa and reviewed four of these for definitions of GDM.",
            "startOffset": 20806,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for gestational diabetes mellitus as an adverse events following immunization"
        },
        {
            "endOffset": 14804,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Given the risk for significant maternal and fetal morbidity and mortality in pregnancies complicated by GDM, strict glycemic control during pregnancy is recommended [11,12] it is also important to be cognizant of medications that may cause transient hyperglycemia or that exacerbate hyperglycemia in mothers with GDM, such as beta-adrenergic agents and corticosteroids that are often administered to women with threatened preterm labor [13].",
            "startOffset": 14363,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for gestational diabetes mellitus as an adverse event following immunization"
        },
        {
            "endOffset": 16375,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Another confounder to the prior studies is that the true incidence of GDM is not known and ranges widely based on the population examined and the diagnostic criteria used [23].",
            "startOffset": 16199,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for gestational diabetes mellitus as an adverse event following immunization"
        },
        {
            "endOffset": 39466,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                },
                {
                    "id": "s0110",
                    "title": "Data collection"
                }
            ],
            "secId": "s0140",
            "sentence": "Objective clinical evidence supporting classification of the event as \u201cserious\u201d.9",
            "startOffset": 38975,
            "title": "The adverse event"
        },
        {
            "endOffset": 23158,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of gestational diabetes mellitus as an adverse event following immunization"
                }
            ],
            "secId": "s0030",
            "sentence": "It is commonly considered to result from insufficient production of insulin in the pancreas.",
            "startOffset": 23066,
            "title": "Related term(s) of gestational diabetes mellitus"
        },
        {
            "endOffset": 18010,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "This is a missed opportunity, as data comparability across trials or surveillance systems would facilitate data interpretation and promote the scientific understanding of GDM in general, and for our purposes, any possible relationship of maternal vaccination with the development of GDM.",
            "startOffset": 17723,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for gestational diabetes mellitus as an adverse event following immunization"
        },
        {
            "endOffset": 41152,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                }
            ],
            "secId": "s0150",
            "sentence": "The following guidelines represent a desirable standard for analysis of data on GDM to allow for comparability of data, and are recommended as an addition to data analyzed for the specific study question and setting.",
            "startOffset": 40936,
            "title": "Data analysis"
        },
        {
            "endOffset": 48244,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                }
            ],
            "secId": "s0155",
            "sentence": "The instrument of data collection (e.g. standardized questionnaire, diary card, report form).",
            "startOffset": 48151,
            "title": "Data presentation"
        },
        {
            "endOffset": 14012,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Fetal complications of pregnancies with GDM include increased risk of macrosomia, operative delivery, shoulder dystocia, birth trauma and neonatal hypoglycemia and hyperbilirubinemia.",
            "startOffset": 13829,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for gestational diabetes mellitus as an adverse event following immunization"
        },
        {
            "endOffset": 35952,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                },
                {
                    "id": "s0110",
                    "title": "Data collection"
                },
                {
                    "id": "s0120",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "s0130",
            "sentence": "Any medication history (other than treatment for the event described) prior to, during, and after immunization including prescription and non-prescription medication as well as medication or treatment with long half-life or long term effect.",
            "startOffset": 35711,
            "title": "Clinical and immunization history"
        },
        {
            "endOffset": 13130,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "The Global Burden of Disease Project and IDF estimate that the rates of T2DM, including those of reproductive-age women, will continue to rise annually especially in low- and middle-income countries (LMICs) due to increasing risk factors such as obesity and sedentary lifestyle [4].",
            "startOffset": 12848,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for gestational diabetes mellitus as an adverse event following immunization"
        },
        {
            "endOffset": 35707,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                },
                {
                    "id": "s0110",
                    "title": "Data collection"
                },
                {
                    "id": "s0120",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "s0130",
            "sentence": "Risk factors for GDM including family history of diabetes, GDM in prior pregnancies, eating habits and physical activity, weight or body mass index (BMI) at first prenatal visit.",
            "startOffset": 35529,
            "title": "Clinical and immunization history"
        },
        {
            "endOffset": 24930,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of gestational diabetes mellitus as an adverse event following immunization"
                }
            ],
            "secId": "s0050",
            "sentence": "We considered only vaccinations given during pregnancy, not prior to pregnancy.",
            "startOffset": 24851,
            "title": "Timing post immunization"
        },
        {
            "endOffset": 48486,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                }
            ],
            "secId": "s0155",
            "sentence": "Whether the date of onset (Footnote 3) and/or the date of first observation (Footnote 4) and/or the date of diagnosis (Footnote 5) was used for analysis.",
            "startOffset": 48333,
            "title": "Data presentation"
        },
        {
            "endOffset": 32714,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                }
            ],
            "secId": "s0110",
            "sentence": "These guidelines represent a desirable standard for the collection of data on availability following immunization to allow for comparability of data, and are recommended as an addition to data collected for the specific study question and setting.",
            "startOffset": 32467,
            "title": "Data collection"
        },
        {
            "endOffset": 32827,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                }
            ],
            "secId": "s0110",
            "sentence": "The guidelines are not intended to guide the primary reporting of GDM to a surveillance system or study monitor.",
            "startOffset": 32715,
            "title": "Data collection"
        },
        {
            "endOffset": 34464,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                },
                {
                    "id": "s0110",
                    "title": "Data collection"
                },
                {
                    "id": "s0120",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "s0125",
            "sentence": "For all cases and/or all study participants, as appropriate, the following information should be recorded:",
            "startOffset": 34358,
            "title": "Demographics"
        },
        {
            "endOffset": 44442,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                }
            ],
            "secId": "s0150",
            "sentence": "Analysis may also include other characteristics like qualitative patterns of criteria defining the event.",
            "startOffset": 44337,
            "title": "Data analysis"
        },
        {
            "endOffset": 13828,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "In addition, women with a history of GDM are at higher risk for developing T2DM in the future [7].",
            "startOffset": 13730,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for gestational diabetes mellitus as an adverse event following immunization"
        },
        {
            "endOffset": 22730,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of gestational diabetes mellitus as an adverse event following immunization"
                }
            ],
            "secId": "s0025",
            "sentence": "Diabetes in pregnancy is frequently used to describe pregestational diabetes or is used as an umbrella term for pregestational diabetes AND GDM.",
            "startOffset": 22586,
            "title": "The term gestational diabetes mellitus"
        },
        {
            "endOffset": 22897,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of gestational diabetes mellitus as an adverse event following immunization"
                }
            ],
            "secId": "s0030",
            "sentence": "Pregestational diabetes mellitus (DM): Pregestational DM is the diagnosis of diabetes mellitus prior to pregnancy.",
            "startOffset": 22783,
            "title": "Related term(s) of gestational diabetes mellitus"
        },
        {
            "endOffset": 34952,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                },
                {
                    "id": "s0110",
                    "title": "Data collection"
                },
                {
                    "id": "s0120",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "s0125",
            "sentence": "Infant\u2019s name and identifier (medical record number/booking number/subject number or alpha-numeric code) should also be recorded.",
            "startOffset": 34823,
            "title": "Demographics"
        },
        {
            "endOffset": 41284,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                }
            ],
            "secId": "s0150",
            "sentence": "Reported events should be classified in one of the following five categories including the three levels of diagnostic certainty.",
            "startOffset": 41156,
            "title": "Data analysis"
        },
        {
            "endOffset": 43611,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                }
            ],
            "secId": "s0150",
            "sentence": "Subjects with gestational diabetes mellitus by interval to presentation",
            "startOffset": 43540,
            "title": "Data analysis"
        },
        {
            "endOffset": 31373,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Case definition of gestational diabetes mellitus3If the reporting center is different from the vaccinating center, appropriate and timely communication of the adverse event should occur.3"
                }
            ],
            "secId": "s0100",
            "sentence": "Ideally, a postpartum or interpregnancy glucose tolerance test would be performed to confirm that the diagnosis of diabetes mellitus is confined to pregnancy and to exclude diabetes mellitus outside of pregnancy.",
            "startOffset": 31161,
            "title": "Major and minor criteria used in the case definition of gestational diabetes mellitus"
        },
        {
            "endOffset": 30382,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Case definition of gestational diabetes mellitus3If the reporting center is different from the vaccinating center, appropriate and timely communication of the adverse event should occur.3"
                }
            ],
            "secId": "s0095",
            "sentence": "Use of Hemoglobin A1c alone for the diagnosis of GDM without a diagnostic oral glucose tolerance test (OGTT) or elevated fasting plasma glucose level",
            "startOffset": 30233,
            "title": "Insufficient evidence for diagnosis of gestational diabetes mellitus"
        },
        {
            "endOffset": 14362,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "In addition, in utero exposure to maternal hyperglycemia may predispose to obesity and insulin resistance later in life [9,10].",
            "startOffset": 14235,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for gestational diabetes mellitus as an adverse event following immunization"
        },
        {
            "endOffset": 44336,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                }
            ],
            "secId": "s0150",
            "sentence": "If more than one measurement of a particular criterion is taken and recorded, the value corresponding to the greatest magnitude of the adverse experience could be used as the basis for analysis.",
            "startOffset": 44142,
            "title": "Data analysis"
        },
        {
            "endOffset": 38926,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                },
                {
                    "id": "s0110",
                    "title": "Data collection"
                }
            ],
            "secId": "s0140",
            "sentence": "Treatment given for GDM especially specify whether diet-controlled or whether hyperglycemic agents were used and dosing.",
            "startOffset": 38806,
            "title": "The adverse event"
        },
        {
            "endOffset": 43381,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                }
            ],
            "secId": "s0150",
            "sentence": "The interval between immunization and reported GDM could be defined as the date/time of immunization to the date/time of onset (Footnote 3) of the first abnormal glucose measurement.",
            "startOffset": 43199,
            "title": "Data analysis"
        },
        {
            "endOffset": 30016,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Case definition of gestational diabetes mellitus3If the reporting center is different from the vaccinating center, appropriate and timely communication of the adverse event should occur.3"
                }
            ],
            "secId": "s0090",
            "sentence": "All participants in maternal immunization trials should have at minimum a fasting venous blood or capillary glucose sample prior to vaccination.",
            "startOffset": 29872,
            "title": "Level 3 of diagnostic certainty"
        },
        {
            "endOffset": 42432,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                }
            ],
            "secId": "s0150",
            "sentence": "Event meets case definition",
            "startOffset": 42405,
            "title": "Data analysis"
        },
        {
            "endOffset": 46939,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                }
            ],
            "secId": "s0155",
            "sentence": "Although immunization safety surveillance systems denominator data are usually not readily available, attempts should be made to identify approximate denominators.",
            "startOffset": 46776,
            "title": "Data presentation"
        },
        {
            "endOffset": 15754,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "This timing makes determining the actual effect of vaccines on glucose tolerance difficult.",
            "startOffset": 15663,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for gestational diabetes mellitus as an adverse event following immunization"
        },
        {
            "endOffset": 25228,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of gestational diabetes mellitus as an adverse event following immunization"
                }
            ],
            "secId": "s0050",
            "sentence": "Some medications used in pregnancy, such as corticosteroids and beta-mimetics, which can result in transient hyperglycemia which can last from hours to several days.",
            "startOffset": 25063,
            "title": "Timing post immunization"
        },
        {
            "endOffset": 48746,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                }
            ],
            "secId": "s0155",
            "sentence": "Use of this case definition for GDM, in the abstract or methods section of a publication.13",
            "startOffset": 48487,
            "title": "Data presentation"
        },
        {
            "endOffset": 23641,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of gestational diabetes mellitus as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "It needs to be emphasized that the grading of definition levels is entirely about diagnostic certainty, not clinical severity of an event.",
            "startOffset": 23503,
            "title": "Formulating a case definition that reflects diagnostic certainty: weighing specificity versus sensitivity"
        },
        {
            "endOffset": 31853,
            "parents": [],
            "secId": "s0105",
            "sentence": "It was the consensus of the Brighton Collaboration Gestational Diabetes Mellitus Working Group to recommend the following guidelines to enable meaningful and standardized collection, analysis, and presentation of information about gestational diabetes.",
            "startOffset": 31601,
            "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
        },
        {
            "endOffset": 27713,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0065",
            "sentence": "Similar to all Brighton Collaboration case definitions and guidelines, review of the definition with its guidelines is planned on a regular basis (i.e. every three to five years) or more often if needed.",
            "startOffset": 27510,
            "title": "Periodic review"
        },
        {
            "endOffset": 22245,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "The full reference list of documents, consensus guidelines and textbooks are available upon request.",
            "startOffset": 22145,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for gestational diabetes mellitus as an adverse events following immunization"
        },
        {
            "endOffset": 48912,
            "parents": [],
            "secId": "s0160",
            "sentence": "The findings, opinions and assertions contained in this consensus document are those of the individual scientific professional members of the working group.",
            "startOffset": 48756,
            "title": "Disclaimer"
        },
        {
            "endOffset": 17722,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "There is hence no uniformly accepted definition of Gestational Diabetes Mellitus.",
            "startOffset": 17641,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for gestational diabetes mellitus as an adverse event following immunization"
        },
        {
            "endOffset": 28625,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Case definition of gestational diabetes mellitus3If the reporting center is different from the vaccinating center, appropriate and timely communication of the adverse event should occur.3"
                }
            ],
            "secId": "s0080",
            "sentence": "Absence of pregestational diabetes mellitus diagnosis in the first trimester as defined above with level 1\u20132 certainty for gestational age using GAIA definition for gestational age (please see Appendix A)",
            "startOffset": 28421,
            "title": "Level 1 of diagnostic certainty"
        },
        {
            "endOffset": 42492,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                }
            ],
            "secId": "s0150",
            "sentence": "Level 1: Criteria as specified in the GDM case definition",
            "startOffset": 42435,
            "title": "Data analysis"
        },
        {
            "endOffset": 12722,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "The incidence of GDM follows the incidence of insulin-resistance and type 2 diabetes mellitus (T2DM) in a given country\u2019s population [2].",
            "startOffset": 12585,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for gestational diabetes mellitus as an adverse event following immunization"
        },
        {
            "endOffset": 17472,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "While the gold standard for diagnosis of GDM is an oral glucose tolerance test, the blood glucose cut-offs often vary between and within countries, and sampling methodology can range from laboratory results based on venous serum samples to plasma samples using calibrated handheld glucometers [24].",
            "startOffset": 17174,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for gestational diabetes mellitus as an adverse event following immunization"
        },
        {
            "endOffset": 24726,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of gestational diabetes mellitus as an adverse event following immunization"
                },
                {
                    "id": "s0040",
                    "title": "Rationale for individual criteria or decision made related to the case definition"
                }
            ],
            "secId": "s0045",
            "sentence": "Please see laboratory criteria listed below (Section 2).",
            "startOffset": 24670,
            "title": "Laboratory findings"
        },
        {
            "endOffset": 26268,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of gestational diabetes mellitus as an adverse event following immunization"
                }
            ],
            "secId": "s0050",
            "sentence": "Instead, where feasible, details of this interval should be assessed and reported as described in the data collection guidelines.",
            "startOffset": 26139,
            "title": "Timing post immunization"
        },
        {
            "endOffset": 45090,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                }
            ],
            "secId": "s0150",
            "sentence": "Data on GDM obtained from subjects receiving a vaccine should be compared with those obtained from an appropriately selected and documented control group(s) to assess background rates of hypersensitivity in non-exposed populations, and should be analyzed by study arm and dose where possible, e.g. in prospective clinical trials.",
            "startOffset": 44761,
            "title": "Data analysis"
        },
        {
            "endOffset": 26138,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of gestational diabetes mellitus as an adverse event following immunization"
                }
            ],
            "secId": "s0050",
            "sentence": "Therefore, to avoid selection bias, a restrictive time interval from immunization to onset of GDM should not be an integral part of such a definition.",
            "startOffset": 25988,
            "title": "Timing post immunization"
        },
        {
            "endOffset": 48332,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                }
            ],
            "secId": "s0155",
            "sentence": "Whether the day of immunization was considered \u201cday one\u201d or \u201cday zero\u201d in the analysis.",
            "startOffset": 48245,
            "title": "Data presentation"
        },
        {
            "endOffset": 19161,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "The search term for Pubmed is shown below and was modified for Embase search terminology:",
            "startOffset": 19072,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for gestational diabetes mellitus as an adverse events following immunization"
        },
        {
            "endOffset": 44757,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                }
            ],
            "secId": "s0150",
            "sentence": "When only a small number of cases is presented, the respective values or time course can be presented individually.",
            "startOffset": 44642,
            "title": "Data analysis"
        },
        {
            "endOffset": 18510,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "Following the process described on the Brighton Collaboration Website http://www.brightoncollaboration.org/internet/en/index/process.html, the Brighton Collaboration Gestational Diabetes Working Group was formed in 2016 and included members from clinical, academic, public health, and industry backgrounds.",
            "startOffset": 18204,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for gestational diabetes mellitus as an adverse events following immunization"
        },
        {
            "endOffset": 23801,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of gestational diabetes mellitus as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "Thus, a clinically very severe event may appropriately be classified as Level Two or Three rather than Level One if it could reasonably be of non-GDM etiology.",
            "startOffset": 23642,
            "title": "Formulating a case definition that reflects diagnostic certainty: weighing specificity versus sensitivity"
        },
        {
            "endOffset": 38702,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                },
                {
                    "id": "s0110",
                    "title": "Data collection"
                }
            ],
            "secId": "s0140",
            "sentence": "Method of measurement (e.g. serum sampling or fingerstick for capillary glucose measurements, type of thermometer, oral or other route, duration of measurement, etc.);",
            "startOffset": 38535,
            "title": "The adverse event"
        },
        {
            "endOffset": 14991,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "The association between maternal immunization and GDM, whether the development or exacerbation of the disease, or even the mitigation of disease, has not been well studied and is unknown.",
            "startOffset": 14804,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for gestational diabetes mellitus as an adverse event following immunization"
        },
        {
            "endOffset": 21127,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "A flow diagram of identified sources is shown in Fig. 1.",
            "startOffset": 21071,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for gestational diabetes mellitus as an adverse events following immunization"
        },
        {
            "endOffset": 19537,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "(gestational diabetes/diagnosis OR (Diabetes mellitus AND diagnosis AND pregnancy) OR \u201cdiabetes in pregnancy\u201d OR Glucose intolerance of pregnancy OR hyperglycemia in pregnancy OR hyperglucosuria) Filters: Systematic Reviews; published in the last 5 years; Humans; English)",
            "startOffset": 19265,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for gestational diabetes mellitus as an adverse events following immunization"
        },
        {
            "endOffset": 36018,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                },
                {
                    "id": "s0110",
                    "title": "Data collection"
                },
                {
                    "id": "s0120",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "s0130",
            "sentence": "(e.g. immunoglobulins, blood transfusion and immunosuppressants).",
            "startOffset": 35953,
            "title": "Clinical and immunization history"
        },
        {
            "endOffset": 13311,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "The pathophysiology for GDM centers around the inability of a pregnant woman to develop an adequate insulin response to a glucose load to maintain her blood sugar in a normal range.",
            "startOffset": 13130,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for gestational diabetes mellitus as an adverse event following immunization"
        },
        {
            "endOffset": 28017,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Case definition of gestational diabetes mellitus3If the reporting center is different from the vaccinating center, appropriate and timely communication of the adverse event should occur.3"
                }
            ],
            "secId": "s0075",
            "sentence": "Gestational diabetes mellitus (GDM) is a clinical syndrome characterized by",
            "startOffset": 27942,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 21653,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "Findings of the literature search included varying definitions of gestational diabetes mellitus in the literature as well as different diagnostic criteria described in the systematic reviews and research studies.",
            "startOffset": 21441,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for gestational diabetes mellitus as an adverse events following immunization"
        },
        {
            "endOffset": 28800,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Case definition of gestational diabetes mellitus3If the reporting center is different from the vaccinating center, appropriate and timely communication of the adverse event should occur.3"
                }
            ],
            "secId": "s0080",
            "sentence": "Diagnosis of gestational diabetes based on a positive internationally recognized oral glucose tolerance test (see below \u201cmajor criteria\u201d) using venous blood sample/samples.",
            "startOffset": 28628,
            "title": "Level 1 of diagnostic certainty"
        },
        {
            "endOffset": 24149,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of gestational diabetes mellitus as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "The case definition has been formulated such that the Level 1 definition is highly specific for the condition.",
            "startOffset": 24039,
            "title": "Formulating a case definition that reflects diagnostic certainty: weighing specificity versus sensitivity"
        },
        {
            "endOffset": 13729,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "GDM places mothers at increased risk for gestational hypertension, pre-eclampsia and cesarean section during pregnancy [6].",
            "startOffset": 13606,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for gestational diabetes mellitus as an adverse event following immunization"
        },
        {
            "endOffset": 36363,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                },
                {
                    "id": "s0110",
                    "title": "Data collection"
                }
            ],
            "secId": "s0135",
            "sentence": "Date and time of immunization(s).",
            "startOffset": 36330,
            "title": "Details of the immunization"
        },
        {
            "endOffset": 34113,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                },
                {
                    "id": "s0110",
                    "title": "Data collection"
                }
            ],
            "secId": "s0115",
            "sentence": "Name and contact information of person reporting (Footnote 2) and/or diagnosing the GDM as specified by country-specific data protection law.",
            "startOffset": 33972,
            "title": "Source of information/reporter"
        },
        {
            "endOffset": 25449,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of gestational diabetes mellitus as an adverse event following immunization"
                }
            ],
            "secId": "s0050",
            "sentence": "Given the paucity of identified information about GDM associated with vaccination, we are unable to provide an evidence-based estimate of time interval for the possible development of GDM following maternal immunization.",
            "startOffset": 25229,
            "title": "Timing post immunization"
        },
        {
            "endOffset": 38802,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                },
                {
                    "id": "s0110",
                    "title": "Data collection"
                }
            ],
            "secId": "s0140",
            "sentence": "Results of laboratory examinations, surgical and/or pathological findings and diagnoses if present.",
            "startOffset": 38703,
            "title": "The adverse event"
        },
        {
            "endOffset": 20626,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "Two committee members reviewed the literature search results for duplications and appropriateness to the topic, retaining 111 of 209 included documents.",
            "startOffset": 20474,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for gestational diabetes mellitus as an adverse events following immunization"
        },
        {
            "endOffset": 46666,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                }
            ],
            "secId": "s0155",
            "sentence": "Terms to describe GDM such as \u201cwell-controlled\u201d, \u201cpoorly controlled\u201d, \u201clow-grade\u201d, \u201cmild\u201d, \u201cmoderate\u201d, \u201chigh\u201d, \u201csevere\u201d or \u201csignificant\u201d are highly subjective, prone to wide interpretation, and should be avoided, unless clearly defined.",
            "startOffset": 46430,
            "title": "Data presentation"
        },
        {
            "endOffset": 12847,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "The prevalence of GDM can range anywhere from 1% to 15% depending on screening methods used, risk factors and ethnicity [3].",
            "startOffset": 12723,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for gestational diabetes mellitus as an adverse event following immunization"
        },
        {
            "endOffset": 44037,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                }
            ],
            "secId": "s0150",
            "sentence": "The duration of a possible GDM could be analyzed as the interval between the date/time of onset (Footnote 2) of the first symptoms and/or signs consistent with the definition and the end of episode (Footnote 6) and/or final outcome (Footnote 7).",
            "startOffset": 43792,
            "title": "Data analysis"
        },
        {
            "endOffset": 41427,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                }
            ],
            "secId": "s0150",
            "sentence": "Events that meet the case definition should be classified according to the levels of diagnostic certainty as specified in the case definition.",
            "startOffset": 41285,
            "title": "Data analysis"
        },
        {
            "endOffset": 34318,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                },
                {
                    "id": "s0110",
                    "title": "Data collection"
                }
            ],
            "secId": "s0115",
            "sentence": "Relation to the patient (e.g., immunizer [clinician, nurse], family member [indicate relationship], other).",
            "startOffset": 34211,
            "title": "Source of information/reporter"
        },
        {
            "endOffset": 22144,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "An inventory spreadsheet of definitions and diagnostic criteria of the 141 pieces of literature as well as a summary page comparing the most common guidelines for the definition of gestational diabetes was made available to working group members.",
            "startOffset": 21898,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for gestational diabetes mellitus as an adverse events following immunization"
        },
        {
            "endOffset": 19891,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "A separate search was done to identify any studies or reports associating gestational diabetes mellitus with immunizations and vaccinations, using MEDLINE, Embase, the Cochrane Database of Systematic Reviews, Clinical Key medical reference books, and the Centers for Disease Control and Prevention (CDC) and National Institutes for Health (NIH) websites.",
            "startOffset": 19537,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for gestational diabetes mellitus as an adverse events following immunization"
        },
        {
            "endOffset": 24501,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of gestational diabetes mellitus as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "In this way it is hoped that all possible cases of GDM can be captured.",
            "startOffset": 24430,
            "title": "Formulating a case definition that reflects diagnostic certainty: weighing specificity versus sensitivity"
        },
        {
            "endOffset": 17173,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Recommendations for GDM screening in pregnancy, usually between 24 and 28 weeks gestational age, are increasingly becoming universal, however, are often based on risk factors in resource-limited settings.",
            "startOffset": 16969,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for gestational diabetes mellitus as an adverse event following immunization"
        },
        {
            "endOffset": 38971,
            "parents": [
                {
                    "id": "s0105",
                    "title": "Guidelines for data collection, analysis and presentation of gestational diabetes mellitus"
                },
                {
                    "id": "s0110",
                    "title": "Data collection"
                }
            ],
            "secId": "s0140",
            "sentence": "Outcome (Footnote 7) at last observation.",
            "startOffset": 38930,
            "title": "The adverse event"
        },
        {
            "endOffset": 12407,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "According to the International Diabetes Federation (IDF), about 16.8% of live-births are born to women with hyperglycemia in pregnancy [1].",
            "startOffset": 12268,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for gestational diabetes mellitus as an adverse event following immunization"
        }
    ],
    "docId": "S0264410X17301044",
    "metadata": {
        "asjc": [
            "1313",
            "2400",
            "2725",
            "2739",
            "3400"
        ],
        "authors": [
            {
                "email": null,
                "first": "Alisa",
                "initial": "A.",
                "last": "Kachikis"
            },
            {
                "email": null,
                "first": "Linda O.",
                "initial": "L.O.",
                "last": "Eckert"
            },
            {
                "email": null,
                "first": "Christie",
                "initial": "C.",
                "last": "Walker"
            },
            {
                "email": null,
                "first": "Eugene",
                "initial": "E.",
                "last": "Oteng-Ntim"
            },
            {
                "email": null,
                "first": "Rama",
                "initial": "R.",
                "last": "Guggilla"
            },
            {
                "email": null,
                "first": "Manish",
                "initial": "M.",
                "last": "Gupta"
            },
            {
                "email": null,
                "first": "Manasi",
                "initial": "M.",
                "last": "Patwardhan"
            },
            {
                "email": null,
                "first": "Ronald",
                "initial": "R.",
                "last": "Mataya"
            },
            {
                "email": null,
                "first": "Tamala",
                "initial": "T.",
                "last": "Mallett Moore"
            },
            {
                "email": null,
                "first": "Ana Maria",
                "initial": "A.M.",
                "last": "Alguacil-Ramos"
            },
            {
                "email": null,
                "first": "Cheryl",
                "initial": "C.",
                "last": "Keech"
            },
            {
                "email": null,
                "first": "Michael",
                "initial": "M.",
                "last": "Gravett"
            },
            {
                "email": null,
                "first": "Helen",
                "initial": "H.",
                "last": "Murphy"
            },
            {
                "email": null,
                "first": "Sonali",
                "initial": "S.",
                "last": "Kochhar"
            },
            {
                "email": "NChescheir@greenjournal.org",
                "first": "Nancy",
                "initial": "N.",
                "last": "Chescheir"
            },
            {
                "email": null,
                "first": null,
                "initial": null,
                "last": null
            }
        ],
        "doi": "10.1016/j.vaccine.2017.01.043",
        "firstpage": "6555",
        "issn": "0264410X",
        "lastpage": "6562",
        "openaccess": "Full",
        "pub_year": 2017,
        "subjareas": [
            "BIOC",
            "IMMU",
            "MEDI",
            "VETE"
        ],
        "title": "Gestational diabetes mellitus: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data"
    }
}